Sharing learning from the HepCATT trial

The Hepatitis C Assessment Through to Treatment Trial (HepCATT) investigated a multi-part intervention to increase the identification and treatment of patients with hepatitis C in primary care. We are sharing the learning from this trial to support the implementation of the NHS England Hepatitis C Virus Elimination Initiative in Primary Care.

Researchers from the University of Bristol's NIHR Health Protection Research Unit in Behavioural Science and Evaluation and Centre for Academic Primary Care investigated an algorithm to identify patients at risk of the hepatitis C virus (HCV) in primary care through the HepCATT (Hepatitis C Assessment Through to Treatment) randomised controlled trial.

The intervention was found to be effective, acceptable to staff and highly cost-effective for the NHS.

When conducting HepCATT we learnt some useful lessons about how to implement the intervention, which we hope will be helpful to NHS England and GP practice staff taking part in the NHS England programme.

Find out more and watch the video explainer: